Track Categories

The track category is the heading under which your abstract will be reviewed and later published in the conference printed matters if accepted. During the submission process, you will be asked to select one track category for your abstract.

Disease is the enemy of mankind, which affects part or all of organism.  Efforts to cure or improve the health condition against disease lead a remarkable improvement in the field of pharma. Pharmaceutical science is a wide range of combinations of scientific disciplines that contribute to the discovery and development of new drugs and pharmacotherapies. Advancements in the branches of pharmaceutical sciences enhance the development of new reliable pharma entities. Every aspect of the pharmaceutical science deals with the design, action, delivery, and disposition of drugs. The Economist Intelligence Unit (EIU) reports that health care spending in the 60 countries that it covers rose by 2.6 percent in nominal U.S. dollar terms in 2014. Global health care spending is expected to increase by an average of 4.3 percent in 2015-2019. And the Size of the pharma market in EU set to grow by 27% between 2015- & 2022.

  • Track 1-1Biopharmaceutics
  • Track 1-2Pharmacogenomics
  • Track 1-3Bio informatics
  • Track 1-4Pharmaceutical Microbiology and Sterilization
  • Track 1-5Pharmaceutical Jurisprudence
  • Track 1-6Pharmacoepidemiology

Persistent innovative development is one of the eminent characters of pharmaceutical industry. Pharmaceutical innovation is an orderly, predictable process. Intensive research coverage, giving rise to abundant but relatively dispersed knowledge of the mechanisms driving pharma drug discovery and development. The invention of new medicines, and the improvement of existing drugs constitute the development firms in pharmaceutical industry. The occasional triumph of creating a novel therapy in an area with no prior treatments counts among the pharmaceutical industry’s most defining hallmarks.

Germany is forecast to have highest increase in pharmaceutical market value at € 11.4bn. Novartis is forecast to reduce its pharma R&D spending, from $10.5bn in 2020 to only $9.2bn in 2022. Of the top 20 pharmaceutical industries, Celgene and Regeneron are forecast to grow their pharma R&D expenses most rapidly, with R&D spend forecast to increase 11% per year until 2022. Overall, total pharma R&D spends is expected to increase by 2.8% each year, reaching $182bn in 2022

  • Track 2-1Criteria for Target Selection
  • Track 2-2Genomic Technologies
  • Track 2-3Proteomic Technologies
  • Track 2-4Quality by Design
  • Track 2-5Random Screening
  • Track 2-6Molecular Designing
  • Track 2-7Challenges in Drug Discovery
  • Track 2-8Advancements of In vitro studies
  • Track 2-9Enhancements of In vivo studies

Clinical trials are the clinical investigation of a drug that administered or dispensed to, or used involving one or more human subjects. Clinical trials are the major parameter for the approval of drug, as they mainly deals with the effectiveness and safety.  Clinical trials plays a vital role in the development of new drug entity as it subjected to various phases for approval . Advancements in  clinical trials enhances the drug development process by means of reducing time duration, sometimes the cost.

The success rate of Phase II trials that proceed to Phase III, as of 2010, is 18%. The amount of money spent on Phase II/III trials in 2015 by Large Sponsors (R&D $500M+) was $465,725,000 on average, while Non-Large Sponsors (R&D <$500M) spent $13,352,000 on average. The entire process of a drug from lab to this point may take approximately 12 to 18 years (but not always), often costing over $1 billion.

  • Track 3-1Role of Clinical Trials
  • Track 3-2Goals of Preclinical studies
  • Track 3-3Safety potential results of Preclinical studies
  • Track 3-4Overcoming hurdles in Clinical Trials
  • Track 3-5Meeting the requirements of FDA review process
  • Track 3-6Safety and Effectiveness of Drug

It deals with prevention of  adverse drug reaction by collection, detection, assessment, monitoring. It concerns with the identifying hazards associated with pharmaceutical formulation. The advancement associated with pharmacovigilance helps in producing the valid formulation by focussing on the collected data from patients and health care providers.

Patient awareness regarding adverse drug events is stimulating global pharmacovigilance market growth by increase in number of national pharmacovigilance centers. Spain pharmacovigilance market size was valued over USD 230 million in 2015 and witness 10.2% CAGR from 2016 to 2024, to surpass USD 550 million by 2024

  • Track 4-1Adverse Event Reporting
  • Track 4-2Risk Management Plans
  • Track 4-3The Importance of Pharmacovigilance, Safety Monitoring of Medicinal Products
  • Track 4-4Role of Pharmacovigilance Centres

Pharmacognosy is the study of drugs derived from Plants and herbs. The Drugs from natural sources can be obtained by the help of following methods like Computational chemistry, Medicinal chemistry, Molecular drug design, Protein structure prediction, Molecular simulation, and Exploratory development and Biochemistry.

Global sales of plant products was totally estimated us $60 billion in 2002 and is expected to get higher at 6.4 % average growth rate

  • Track 5-1Natural Sources
  • Track 5-2Computational chemistry
  • Track 5-3Medicinal chemistry
  • Track 5-4Molecular drug design
  • Track 5-5Protein structure prediction

Pharmacology is the study of the biochemical and physiological effects of active ingredient on humans. The various aspects of pharmacological sciences are Behaviouralpharmacology, MedicalPharmacology, Cardiovascular pharmacology, Endocrine pharmacology, Clinical pharmacology, Urogenital pharmacology, Pharmacokinetics, Neuropharmacology, Immune pharmacology, Cognitive models of the brain, Neural models of memory, Functional modes of the brain, Neuropsychology, Cognitive neuroscience and neurosystems.

The drug market was valued at nearly $5.8 billion during 2011 and will reach nearly $5.7 billion during 2012. Total value is expected to reach nearly $6 billion in 2018

  • Track 6-1Behaviouralpharmacology
  • Track 6-2Cardiovascular pharmacology
  • Track 6-3Endocrine pharmacology
  • Track 6-4Pharmacokinetics
  • Track 6-5Neuropharmacology
  • Track 6-6Immune pharmacology

Drugs and Regulations are very important in aspects of Pharmaceutical sciences where it deals with Drug safety, Cost effectiveness, Drug rediscovery, Pharmaceutical services, Role of pharmacists, Radio Pharmaceuticals and Multiple drug use etc. The regulation of drugs varies by jurisdiction. In some countries, such as the United States, they are regulated at the national level by a single agency. In other jurisdictions they are regulated at the state level or at both state and national levels by various bodies, as is the case in Australia.

  • Track 7-1Drug safety
  • Track 7-2Drug rediscovery
  • Track 7-3Pharmaceutical services
  • Track 7-4Role of pharmacists
  • Track 7-5Radio Pharmaceuticals and Multiple drug use

Pharmacotherapy deals in administering pharmaceutical drugs distinguishing from therapy using surgery, radiation, movement or other methods. Drug therapy complies patient care with various types of pharmaceutical drugs ensuring the safe, appropriate and economical use. North America is expected to account for more than half the therapeutic drug monitoring market share in 2015. It is the prime market for therapeutic drug monitoring. The market in Europe on the other hand is growing at a slower rate. Therapeutic Drug Monitoring Market’s worth is expected 2.55 Billion USD by 2020 globally.

  • Track 8-1Effective ways of Drug Therapy
  • Track 8-2Adverse Effects in Drug Therapy
  • Track 8-3Drug therapy problem for seamless monitoring (DTPsm)
  • Track 8-4 Drug Therapy Monitoring
  • Track 8-5 Therapeutic index

Practically speaking, it involves chemical aspects of identification, and then systematic, thorough synthetic alteration of new chemical entities to make them suitable for therapeutic use. It includes synthetic and computational aspects of the study of existing drugs and agents in development in relation to their bioactivities i.e., understanding their structure-activity relationships (SAR). Pharmaceutical chemistry is focused on quality aspects of medicines and aims to assure fitness for purpose of medicinal products.

The chemical industry is one of the world’s largest branches and has significant influence on many other industries. Total global chemical shipments are worth an enormous five billion U.S. dollars.

  • Track 9-1Structural Activity Relationship
  • Track 9-2Medicinal products

Pharmaceutical formulations, in pharmaceutics, are the process in which different chemical substances, including the active drug, are combined to produce a final medicinal product. The word formulation is often used in a way that includes dosage form. Formulation studies involve developing a preparation of the drug which is both stable and acceptable to the patient. For orally taken drugs, this usually involves incorporating the drug into a tablet or a capsule.

  • Track 10-1Capsule
  • Track 10-2Medicinal products
  • Track 10-3Formulation study

Sometimes called, molecular manufacturing is a branch of engineering that deals with the design and manufacture of extremely small electronic circuits and mechanical devices built at the molecular level of matter. Nanotechnology is also being applied to or developed for application to a variety of industrial and purification processes. Purification and environmental clean-up applications include the desalination of water, water filtration, wastewater treatment, groundwater treatment, and other Nano remediation.

The global market for nanotechnology dots was estimated to generate $121.0 million in revenues in 2013. This market is expected to reach about $1.1 billion in 2016 and about $3.1 billion by 2018, at a compound annual growth rate (CAGR) of 90.8% for the five-year period, 2013 to 2018

  • Track 11-1Molecular manufacturing
  • Track 11-2Desalination
  • Track 11-3Mechanical devices
  • Track 11-4Nano remediation

The method by which a drug is delivered can have a significant effect on its efficacy. Some drugs have an optimum concentration range within which maximum benefit is derived, and concentrations above or below this range can be toxic or produce no therapeutic benefit at all. On the other hand, the very slow progress in the efficacy of the treatment of severe diseases, has suggested a growing need for a multidisciplinary approach to the delivery of therapeutics to targets in tissues

  • Track 12-1Efficacy
  • Track 12-2Therapeutic benefit
  • Track 12-3Optimum concentration

The drug discovery starts with Pre-formulation Studies which is initiated by Disease Identification then carried onto suitable drug identification then after Stability Analysis of Drug, Behaviour Analysis, Dissolution, High Performance Liquid Chromatography or Nuclear Magnetic Resonance (NMR) as per the ICH guidelines.

The global market for Pre-formulation studies that is for the drug discovery technologies reached nearly $39.5 billion and $46.5 billion in 2013 and 2014, respectively. This market is expected to grow at a compound annual growth rate (CAGR) of 11.3% to nearly $79.5 billion for the period 2014-2019

  • Track 13-1Disease Identification
  • Track 13-2Drug identification
  • Track 13-3Stability Analysis of Drug
  • Track 13-4Behaviour Analysis
  • Track 13-5Dissolution

Bio Pharmaceutics plays an important role in drug discovery like drug disposition, Innovations in clinical development, Pharmaceutical technology, Pharmaceutics and drug delivery, Drug design, Targeted drug, gene delivery, Sustained drug delivery system, Routes of administration, Fundamental drug development.

The global market for quantum dots (QDs) was estimated to generate $121 million in revenues in 2013. This market is expected to reach about $1.1 billion in 2016 and about $3.1 billion by 2018, at a compound annual growth rate (CAGR) of 90.8% for the five-year period, 2013 to 2018.

  • Track 14-1Drug disposition
  • Track 14-2Pharmaceutical technology
  • Track 14-3Pharmaceutics and drug delivery
  • Track 14-4Drug design
  • Track 14-5Gene delivery

Bioinformatics has emerged out of the inputs of specialists from several different areas such as biology, biochemistry, biophysics, molecular biology, and biostatistics and computer science. Specially designed algorithms and organised computer databases are at the core of all bioinformatic operations. Algorithms, that are necessarily complex, make voluminous data easy to handle for defined purposes, in an amazingly short time, a process that is humanly impossible.

The global market for Bioinformatics is expected to grow from nearly $2.3 billion in 2014 to nearly $3.4 billion in 2019, with a compound annual growth rate (CAGR) of 8.3% for the period of 2014-2019.

  • Track 15-1Biology
  • Track 15-2Biochemistry
  • Track 15-3Biophysics
  • Track 15-4Molecular biology
  • Track 15-5Biostatistics and Computer science

Genetics is the study of genes, heredity, and genetic variation in living beings. It is basically considered a field of biology, but it bisect often with many of the life sciences like Pharmaceutical Sciences. The other aspects of this are Genetic engineering, Biomedical Engineering, Genomics Proteomics, Clinical engineering, Tissue engineering, biomedical data engineering etc.

The global genetic engineering market is expected to reach $3,514.08 Million by 2019 from $1,845.25 Million in 2014, growing at a CAGR of 13.75%. Increased RandD expenditure and growth of biotechnology and pharmaceutical industries, increased funding for genomics research, and technological advancements are the primary growth drivers for this market during the forecast period (2014–2019).

  • Track 16-1Biomedical Engineering
  • Track 16-2Genomics Proteomics
  • Track 16-3Clinical engineering
  • Track 16-4Tissue engineering
  • Track 16-5Biomedical data engineering

Packaging is one of the largest industry sectors in the world, worth several billions. Pharmaceutical packaging represents a meagre percentage of this colossal market. The global healthcare industry has seen a shift in paradigm and is now skewed toward effective and meaningful packaging. Packaging was considered as an afterthought which was required merely in the final stages of manufacturing for many pharmaceutical companies about a decade ago.

Radiopharmaceuticals used as Diagnostic and therapeutic agents. The main group of these compounds are used as the radio tracers to diagnose the diseased tissues in a body.

The global radiopharmaceuticals market was worth US$3.8 billion in 2011 and is expected to be growing at a stupendous CAGR of 18.3% to reach a value of US$12.2 billion by 2018.

  • Track 18-1Diagnostic agents
  • Track 18-2Therapeutic agents
  • Track 18-3Radio tracers

Pharma Companies in Europe - Kowa Pharmaceutical, Aegerion Pharmaceuticals Ltd, Kent Pharmaceuticals, Alan Pharmaceuticals, Alliance Pharmaceutical Limited. Pharmaceutical Companies are knowledge driven industry and is heavily dependent on Research and Development for new products and growth. However, basic research discovering of new molecules is a time consuming and expensive process and is thus, dominated by large global multinationals.

  • Track 19-1Aegerion Pharmaceuticals
  • Track 19-2Kent Pharmaceuticals
  • Track 19-3Research and Development

They are experts in the field of medicines and are not only responsible for the dispensing of prescriptions but also the purchase, manufacture and quality testing of all medicines  used in a hospital. Many hospital pharmacists are qualified to prescribe in their own right. Pharmacists work closely with medical and nursing staff to ensure that patients receive the best treatment, advising on the selection, dose and administration route. They also provide help and advice to patients in all aspects of their medicines.

In 2013, there were 287,420 pharmacists and 362,690 pharmacy technicians in the United States. Since 2003, the number of pharmacists in the U.S. has fluctuated year to year, but overall has increased approximately 19% in the last decade. The number of pharmacy technicians steadily increased in the same period, adding over 170,000 workers from 2003-2018

  • Track 20-1Dispensing
  • Track 20-2QualityTesting
  • Track 20-3Purchase
  • Track 20-4Manufacture

Industrial Pharmacy also plays a crucial role in any drug discovery. To any novel drug discovery the industrial approach is very important to get massive commercial application. Few things which have to be considered by industries to provide a safe and cost effective medicine to the patients like Supply chain, Waste management, Product management, Post- marketing surveillance, Good manufacturing practices and Marketing.

The U.S pharmaceutical market is the world’s most important national market. Together with Canada and Mexico, it represents the largest continental pharma market worldwide. TheUnited States alone holds some 40 percent of the global pharmaceutical market. In 2014, this share was valued around 365 million U.S. dollars.

  • Track 21-1Novel Drug Discovery
  • Track 21-2Product management
  • Track 21-3Post- marketing surveillance
  • Track 21-4Good manufacturing practices and Marketing

Ethics in pharmacy is also very important for the any Pharma Practitioner whether they are from industry or from research institutes or Hospital Pharmacists. Following are the few aspects one must be aware of during the drug discovery and development like NDA (New Drug Application), Adulteration, Misbranding, Exemption in prescription, Experimental animal ethics and Human trial.

  • Track 22-1Adulteration
  • Track 22-2Misbranding
  • Track 22-3Exemption in prescription
  • Track 22-4Experimental animal ethics and Human trial

Nano medicine is simply the application of nanotechnologies in a healthcare setting and the majority of benefits that have already been seen involve the use of nanoparticles to improve the behaviour of drug substances. Today, nanomedicines are used globally to improve the treatments and lives of patients suffering from a range of disorders including ovarian and breast cancer, kidney disease, fungal infections, elevated cholesterol, menopausal symptoms, multiple sclerosis, chronic pain, asthma and emphysema. The nanomedicines that are currently available are overcoming some of the difficulties experienced by normal medical approaches in delivering the benefit from the drug molecules used. In some cases the drugs have very little solubility in water and the human body struggles to absorb enough to treat the condition. In other cases, the drug molecule is absorbed well but the body removes the drug before it has had long enough to provide a benefit. Drugs may lead to side-effects due to poor delivery at the actual site of disease. For example, drugs that are targeting cancers must avoid healthy tissues and organs or damage can be caused. Nanomedicines therefore can play an important role in ensuring enough of the drug enters the body, that drug that does enter stays in the body for long periods and is targeted specifically to the areas that need treatment.

  • Track 23-1Nanotechnologies
  • Track 23-2Kidney disease
  • Track 23-3Fungal infections
  • Track 23-4Menopausal symptoms

The Pharma consultants work with organizations of all sizes including academic institutes, start-up companies, and established organizations. The services aim to increase the patient’s knowledge of their medication and improve their adherence to the regimen.

Globally Pharma Market ranges from $870-$900 billion and in Europe $260-$280 billion from which Germany provides ready access to internationally renowned scientists, world-class research and pharmaceuticals markets.

  • Track 24-1Medication
  • Track 24-2Adherence